HFCAS OpenIR

浏览/检索结果: 共1条,第1-1条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2-Breast Cancer Patient With High Tumor Mutational Burden 期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 10
作者:  Wang, Rong;  Yang, Yuchen;  Ye, Wei-Wu;  Xiang, Jianxing;  Chen, Songan;  Zou, Wei-Bin;  Wang, Xiao-Jia;  Chen, Tianhui;  Cao, Wen-Ming
收藏  |  浏览/下载:53/0  |  提交时间:2021/04/26
breast cancer  immunotherapy  biomarker  TMB  NGS  molecular monitoring